Verona Pharma has blockbuster hopes for its recently approved drug for chronic obstructive pulmonary disorder (COPD), and preliminary sales figures for the drug suggest it is heading in the right ...

Amgen and AstraZeneca have hopes for their asthma drug Tezspire as a potential COPD treatment. Additionally, Regeneron and Sanofi have a second COPD candidate in IL-33 inhibitor itepekimab ...

COPD-asthma-devices-market2025 PORTLAND, DE, UNITED STATES, January 29, 2025 /EINPresswire / -- Day-to-day exposure to environmental pollutio ...

Certain Medicare plans typically cover at least part of the cost of inhalers for COPD. There are also several ways to further save on costs.

You may consider a type of nebulizer for your COPD treatment. These small devices ... holding your breath briefly to allow the drug to enter your system. This can make it more challenging for ...

UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary disease (COPD) drug ensifentrine, setting up regulatory filings in the first half of next year.

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

Asthma–chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS ... randomized clinical trials to evaluate specific drug interventions on important outcomes such as lung function ...

People with COPD experience more falls and related injuries ... Of the 8,204 people, 65% were prescribed at least one fall-risk increasing drug, and 30% had a fall with injury in the two years ...

Medicare Part D and Medicare Advantage (Part C) plans with drug coverage typically cover inhalers for COPD. But you may still be responsible for a portion of the cost. If you have chronic ...